down arrow

Samrat Pharma

46
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE103E01016
  • NSEID:
  • BSEID: 530125
INR
336.00
16 (5.0%)
BSENSE

Apr 11, 12:48 PM

BSE+NSE Vol: 3.33 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is -9.36% vs 40.09% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is -89.68% vs -1.28% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is -44.22% vs 82.61% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is -87.00% vs -3.23% in Mar 2023

Compare Profit and Loss Results of Samrat Pharma
Markets Mojo
Figures in Rs cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
281.00
9,264.00
-8,983.00
-96.97%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
281.00
9,264.00
-8,983.00
-96.97%
Expenditure (Ex Depriciation)
Stock Adjustments
4.00
-25.00
29.00
116.00%
Raw Materials Consumed
265.00
2,933.00
-2,668.00
-90.96%
Power & Fuel Cost
1.00
70.00
-69.00
-98.57%
Employee Cost
2.00
1,982.00
-1,980.00
-99.90%
Operating Expenses
2.00
143.00
-141.00
-98.60%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
806.00
-805.00
-99.88%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
136.00
-136.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
279.00
6,939.00
-6,660.00
-95.98%
Operating Profit (PBDIT) excl Other Income
2.00
2,325.00
-2,323.00
-99.91%
Other Income
1.00
266.00
-265.00
-99.62%
Operating Profit (PBDIT)
3.00
2,592.00
-2,589.00
-99.88%
Interest
0.00
15.00
-15.00
-100.00%
Profit before Depriciation and Tax
3.00
2,577.00
-2,574.00
-99.88%
Depreciation
0.00
317.00
-317.00
-100.00%
Profit Before Taxation & Exceptional Items
2.00
2,259.00
-2,257.00
-99.91%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
2.00
2,259.00
-2,257.00
-99.91%
Provision for Tax
0.00
436.00
-436.00
-100.00%
Profit After Tax
2.00
1,823.00
-1,821.00
-99.89%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
60.00
7,868.00
-7,808.00
-99.24%
Profit Available for appropriations
62.00
9,691.00
-9,629.00
-99.36%
Appropriations
62.00
9,691.00
-9,629.00
-99.36%
Equity Dividend (%)
10%
0%
10.00
Earnings Per Share
7
45.52
-38.52
-84.62%
Profit And Loss - Net Sales
Net Sales 281.58 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -9.36% vs 40.09% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.47 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -89.68% vs -1.28% in Mar 2023

Profit And Loss - Interest
Interest 0.69 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -44.22% vs 82.61% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 2.16 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -87.00% vs -3.23% in Mar 2023